[A study of 152 cases of pulmonary fungal infection: reevaluation of the microbiological spectra].

Bin Cao,Bai-Qiang Cai,Hui Wang,Chao-Yang Zhou,Peng Wang,Hong-Rui Liu,Hong Zhang,Ling Xu,Kai-Feng Xu,Wen-Bing Xu,Yuan-Jue Zhu,Xiao-Guang Li
DOI: https://doi.org/10.3760/j.issn:1001-0939.2007.04.013
2007-01-01
Abstract:OBJECTIVE:To investigate the microbiological spectra and clinical outcome of patients with pulmonary fungal infections. METHODS:All the cases of clinically diagnosed pulmonary fungal infection from January 2002 to June 2006 were reevaluated according to the definitions of European Organization for Research and Treatment of Cancer/National Institute of Allergy and Infectious Diseases Mycosis Study Group (EORTC/MSG), and the etiology of the patients were analyzed. RESULTS:Pulmonary fungal disease was classified as proven (n = 38), probable (n = 24), possible (n = 35) and colonization (n = 55). In the proven group, the most frequently encountered fungi were Aspergillus species (15/38), followed by Cryptococcus species (13/38), Candida species were rare (2/38). In the probable group, Aspergillus species and Aspergillus species + Candida species were among the most common pathogens; while in the possible group and the colonization group, Candida species were most frequently encountered. The mortality of patients with probable pulmonary fungal infection (58.3%) was higher than that of patients in the possible group (25.7%) or the colonization group (16.4%) (P = 0.001). Univariate analysis showed that only APACHE II score was associated with outcome of patients with "pulmonary Candida infections", and antifungal therapy did not improve the outcome of such patients. CONCLUSION:The most frequently encountered fungi in patients with pulmonary fungal infections were Aspergillus species, followed by Cryptococcus species. Primary Candida pulmonary infections were rare.
What problem does this paper attempt to address?